1. Home
  2. HFFG vs ANIX Comparison

HFFG vs ANIX Comparison

Compare HFFG & ANIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo HF Foods Group Inc.

HFFG

HF Foods Group Inc.

HOLD

Current Price

$1.74

Market Cap

104.8M

ML Signal

HOLD

Logo Anixa Biosciences Inc.

ANIX

Anixa Biosciences Inc.

HOLD

Current Price

$2.69

Market Cap

88.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HFFG
ANIX
Founded
1997
1982
Country
United States
United States
Employees
960
N/A
Industry
Food Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
104.8M
88.8M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
HFFG
ANIX
Price
$1.74
$2.69
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$6.00
$8.67
AVG Volume (30 Days)
125.7K
174.0K
Earning Date
05-11-2026
05-27-2026
Dividend Yield
N/A
N/A
EPS Growth
20.65
12.82
EPS
0.02
N/A
Revenue
$1,228,282,000.00
$210,000.00
Revenue This Year
$5.59
N/A
Revenue Next Year
$2.24
N/A
P/E Ratio
$90.00
N/A
Revenue Growth
2.21
N/A
52 Week Low
$1.38
$2.32
52 Week High
$3.86
$5.46

Technical Indicators

Market Signals
Indicator
HFFG
ANIX
Relative Strength Index (RSI) 35.11 52.11
Support Level $1.38 $2.38
Resistance Level $2.30 $3.12
Average True Range (ATR) 0.11 0.21
MACD -0.01 0.03
Stochastic Oscillator 14.67 62.31

Price Performance

Historical Comparison
HFFG
ANIX

About HFFG HF Foods Group Inc.

HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, frozen and dry food, and non-food products to Asian restaurants and other foodservice customers throughout the United States. The company's business consists of one operating segment: HF Group, which operates solely in the United States. The company's product list consists of Meat, Poultry & Seafood, Sauces & Oils, Takeout Items (Boxes, Chopsticks & Utensils), Raw Ingredients (Flour, Cornstarch, Spices), Cleaning Supplies, and Rice & Grains.

About ANIX Anixa Biosciences Inc.

Anixa Biosciences Inc is a biotechnology company developing therapies and vaccines focused on critical unmet needs in oncology. Its operations are organized into reportable segments comprising Cancer Vaccines, CAR-T Therapies, and Other. The Cancer Vaccines segment involves vaccines to treat and prevent breast and ovarian cancer, as well as additional cancer vaccines targeting intractable cancers, including high-incidence malignancies in lung, colon, and prostate. The CAR-T Therapies segment involves the development of liraltagene autoleucel (lira-cel), an ovarian cancer immunotherapy using chimeric endocrine receptor-T cell technology, developed at its subsidiary, Certainty Therapeutics, Inc. The Other segment consists of legacy operations, including limited patent licensing activities.

Share on Social Networks: